文献速递心肺康复骨科与运动康复

动则优活:外周动脉疾病新型监督联合训练的前后对照研究

Move Better, Live Better: A Novel Supervised Combined Training for Peripheral Arterial Disease: A Quasi-experimental Approach.
PubMed 文献 · Am J Phys Med Rehabil · 2025-01-06

本研究采用准实验设计,评估基于间歇平板步行与循环式中等强度功能训练的新型监督运动疗法对外周动脉疾病患者步行能力和健康相关生活质量的影响。所有参与者接受12周监督运动疗法并随访12周,结果显示干预后步行表现和部分生活质量指标较基线显著改善,但随访时改善未维持。

要点

  • 12周监督联合训练可显著改善外周动脉疾病患者最大步行距离、无痛步行距离、步速和峰值摄氧量。
  • 干预后SF-36躯体功能评分和VascuQoL-6评分较基线显著提高。
  • 停止运动随访12周后,基线至随访未见显著差异,提示获益未长期维持。

核心结论

  • 12周基于间歇步行和中等强度功能训练的新型监督运动疗法使外周动脉疾病患者关键功能指标获得显著临床改善。
  • 停止运动后随后数周随访出现显著负面临床变化。

研究设计与样本

  • 准实验研究,所有参与者接受12周监督运动疗法,包含15-30分钟平板步行后接15分钟中等强度功能训练,并继续12周随访。

主要发现

  • 基线至干预后步行表现各项指标差异有统计学意义(P < 0.05):最大步行距离平均差88.53 m,无痛步行距离平均差62.89 m,步速平均差0.24 m·sec⁻¹,峰值摄氧量平均差2.04 ml·kg⁻¹·min⁻¹。
  • 基线至干预后健康相关生活质量有统计学显著差异:SF-36躯体功能平均差6.93分,VascuQoL-6平均差1.46分。
  • 基线至12周随访之间未发现差异。

临床怎么用

  • 对外周动脉疾病患者可考虑采用12周监督下间歇平板步行联合中等强度循环功能训练以改善步行能力和生活质量。
  • 需注意停止训练后获益可能无法维持,应关注长期运动依从性或延续策略。

局限性

  • 原文未报告对照组设置、样本量、随机化方法及盲法信息,准实验设计可能限制因果推断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to analyze the effect of a novel supervised exercise therapy program based on intermittent treadmill walking and circuit-based moderate-intensity functional training on walking performance and health-related quality of life in peripheral arterial disease patients. DESIGN: All participants underwent a 12-wk supervised exercise therapy that involved 15-30 mins of treadmill walking followed by a 15-min moderate-intensity functional training continued by 12-wk follow-up. Maximum walking distance, pain-free walking distance, gait speed, and estimated peak oxygen uptake (peak VO 2 ) were calculated through the 6-min walk test and health-related quality of life through the Short-Form 36 and the Vascular Quality of Life Questionnaire 6. RESULTS: There were statistically significant differences ( P < 0.05) between baseline and postintervention for walking performance outcomes (maximum walking distance [mean difference: 88.53 m], pain-free walking distance [mean difference: 62.89 m], gait speed [mean difference: 0.24 m·sec -1 ], and peak VO2 [mean difference: 2.04 ml·kg -1 ·min -1 ]) and for health-related quality of life (physical functioning in Short-Form 36 [mean difference: 6.93 points] and Vascular Quality of Life Questionnaire 6 [mean difference: 1.46 points]), while no differences were found between baseline and 12-wk follow-up. CONCLUSIONS: Results seem to show that 12-wk novel supervised exercise therapy based on intermittent walking and moderate-intensity functional training induced significant clinical improvements in key functional variables of peripheral arterial disease while cessation of exercise leads to significant negative clinical changes in subsequent weeks of follow-up.

来源:Am J Phys Med Rehabil,查看原文。版权归原作者所有。

引用

  1. Peñín-Grandes S, López-Ortiz S, de la Fuente Gómez M, et al. Move Better, Live Better: A Novel Supervised Combined Training for Peripheral Arterial Disease: A Quasi-experimental Approach. Am J Phys Med Rehabil. 2025. PMID: 39792377. doi:10.1097/PHM.0000000000002706

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。